Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

DVA vs UNH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
DVA
DaVita Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$12.79B
5Y Perf.+139.5%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$333.37B
5Y Perf.+20.5%

DVA vs UNH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
DVA logoDVA
UNH logoUNH
IndustryMedical - Care FacilitiesMedical - Healthcare Plans
Market Cap$12.79B$333.37B
Revenue (TTM)$13.84B$449.71B
Net Income (TTM)$781M$12.04B
Gross Margin31.1%18.8%
Operating Margin15.0%4.2%
Forward P/E13.7x20.1x
Total Debt$15.05B$78.39B
Cash & Equiv.$758M$24.36B

DVA vs UNHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

DVA
UNH
StockMay 20May 26Return
DaVita Inc. (DVA)100239.5+139.5%
UnitedHealth Group … (UNH)100120.5+20.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: DVA vs UNH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: DVA leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. UnitedHealth Group Incorporated is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
DVA
DaVita Inc.
The Income Pick

DVA carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 3 yrs, beta 0.05
  • Lower volatility, beta 0.05, current ratio 1.29x
  • Beta 0.05, current ratio 1.29x
Best for: income & stability and sleep-well-at-night
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 11.8%, EPS growth -14.7%, 3Y rev CAGR 11.4%
  • 220.3% 10Y total return vs DVA's 156.1%
  • 11.8% revenue growth vs DVA's 6.5%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthUNH logoUNH11.8% revenue growth vs DVA's 6.5%
ValueDVA logoDVALower P/E (13.7x vs 20.1x)
Quality / MarginsDVA logoDVA5.6% margin vs UNH's 2.7%
Stability / SafetyDVA logoDVABeta 0.05 vs UNH's 0.59
DividendsUNH logoUNH2.4% yield; 25-year raise streak; the other pay no meaningful dividend
Momentum (1Y)DVA logoDVA+35.9% vs UNH's -4.7%
Efficiency (ROA)DVA logoDVA4.5% ROA vs UNH's 3.9%, ROIC 10.5% vs 9.2%

DVA vs UNH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

DVADaVita Inc.
FY 2025
U S Dialysis And Related Lab Services
100.0%$11.7B
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B

DVA vs UNH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDVALAGGINGUNH

Income & Cash Flow (Last 12 Months)

DVA leads this category, winning 6 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 32.5x DVA's $13.8B. Profitability is closely matched — net margins range from 5.6% (DVA) to 2.7% (UNH). On growth, DVA holds the edge at +6.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricDVA logoDVADaVita Inc.UNH logoUNHUnitedHealth Grou…
RevenueTrailing 12 months$13.8B$449.7B
EBITDAEarnings before interest/tax$2.8B$23.2B
Net IncomeAfter-tax profit$781M$12.0B
Free Cash FlowCash after capex$1.5B$19.7B
Gross MarginGross profit ÷ Revenue+31.1%+18.8%
Operating MarginEBIT ÷ Revenue+15.0%+4.2%
Net MarginNet income ÷ Revenue+5.6%+2.7%
FCF MarginFCF ÷ Revenue+10.8%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year+6.0%+2.0%
EPS Growth (YoY)Latest quarter vs prior year+43.5%+0.7%
DVA leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

DVA leads this category, winning 4 of 6 comparable metrics.

At 20.4x trailing earnings, DVA trades at a 27% valuation discount to UNH's 27.8x P/E. On an enterprise value basis, DVA's 9.9x EV/EBITDA is more attractive than UNH's 16.6x.

MetricDVA logoDVADaVita Inc.UNH logoUNHUnitedHealth Grou…
Market CapShares × price$12.8B$333.4B
Enterprise ValueMkt cap + debt − cash$27.1B$387.4B
Trailing P/EPrice ÷ TTM EPS20.39x27.76x
Forward P/EPrice ÷ next-FY EPS est.13.68x20.06x
PEG RatioP/E ÷ EPS growth rate2.46x
EV / EBITDAEnterprise value multiple9.93x16.61x
Price / SalesMarket cap ÷ Revenue0.94x0.74x
Price / BookPrice ÷ Book value/share14.74x3.29x
Price / FCFMarket cap ÷ FCF9.76x20.74x
DVA leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

DVA leads this category, winning 6 of 9 comparable metrics.

DVA delivers a 59.1% return on equity — every $100 of shareholder capital generates $59 in annual profit, vs $12 for UNH. UNH carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to DVA's 12.99x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs DVA's 5/9, reflecting solid financial health.

MetricDVA logoDVADaVita Inc.UNH logoUNHUnitedHealth Grou…
ROE (TTM)Return on equity+59.1%+11.5%
ROA (TTM)Return on assets+4.5%+3.9%
ROICReturn on invested capital+10.5%+9.2%
ROCEReturn on capital employed+14.0%+9.7%
Piotroski ScoreFundamental quality 0–956
Debt / EquityFinancial leverage12.99x0.77x
Net DebtTotal debt minus cash$14.3B$54.0B
Cash & Equiv.Liquid assets$758M$24.4B
Total DebtShort + long-term debt$15.0B$78.4B
Interest CoverageEBIT ÷ Interest expense3.54x4.71x
DVA leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DVA leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in DVA five years ago would be worth $15,598 today (with dividends reinvested), compared to $9,746 for UNH. Over the past 12 months, DVA leads with a +35.9% total return vs UNH's -4.7%. The 3-year compound annual growth rate (CAGR) favors DVA at 29.5% vs UNH's -7.3% — a key indicator of consistent wealth creation.

MetricDVA logoDVADaVita Inc.UNH logoUNHUnitedHealth Grou…
YTD ReturnYear-to-date+69.3%+9.8%
1-Year ReturnPast 12 months+35.9%-4.7%
3-Year ReturnCumulative with dividends+117.3%-20.4%
5-Year ReturnCumulative with dividends+56.0%-2.5%
10-Year ReturnCumulative with dividends+156.1%+220.3%
CAGR (3Y)Annualised 3-year return+29.5%-7.3%
DVA leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

DVA leads this category, winning 2 of 2 comparable metrics.

DVA is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DVA currently trades 99.9% from its 52-week high vs UNH's 90.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricDVA logoDVADaVita Inc.UNH logoUNHUnitedHealth Grou…
Beta (5Y)Sensitivity to S&P 5000.05x0.59x
52-Week HighHighest price in past year$194.10$404.72
52-Week LowLowest price in past year$101.00$234.60
% of 52W HighCurrent price vs 52-week peak+99.9%+90.7%
RSI (14)Momentum oscillator 0–10059.874.5
Avg Volume (50D)Average daily shares traded781K8.1M
DVA leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

UNH leads this category, winning 1 of 1 comparable metric.

Wall Street rates DVA as "Hold" and UNH as "Buy". Consensus price targets imply 4.9% upside for UNH (target: $385) vs -13.0% for DVA (target: $169). UNH is the only dividend payer here at 2.37% yield — a key consideration for income-focused portfolios.

MetricDVA logoDVADaVita Inc.UNH logoUNHUnitedHealth Grou…
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$168.67$385.43
# AnalystsCovering analysts2352
Dividend YieldAnnual dividend ÷ price+2.4%
Dividend StreakConsecutive years of raises325
Dividend / ShareAnnual DPS$8.70
Buyback YieldShare repurchases ÷ mkt cap+14.0%+1.7%
UNH leads this category, winning 1 of 1 comparable metric.
Key Takeaway

DVA leads in 5 of 6 categories (Income & Cash Flow, Valuation Metrics). UNH leads in 1 (Analyst Outlook).

Best OverallDaVita Inc. (DVA)Leads 5 of 6 categories
Loading custom metrics...

DVA vs UNH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is DVA or UNH a better buy right now?

For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.

8% revenue growth year-over-year, versus 6. 5% for DaVita Inc. (DVA). DaVita Inc. (DVA) offers the better valuation at 20. 4x trailing P/E (13. 7x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — DVA or UNH?

On trailing P/E, DaVita Inc.

(DVA) is the cheapest at 20. 4x versus UnitedHealth Group Incorporated at 27. 8x. On forward P/E, DaVita Inc. is actually cheaper at 13. 7x.

03

Which is the better long-term investment — DVA or UNH?

Over the past 5 years, DaVita Inc.

(DVA) delivered a total return of +56. 0%, compared to -2. 5% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: UNH returned +220. 3% versus DVA's +156. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — DVA or UNH?

By beta (market sensitivity over 5 years), DaVita Inc.

(DVA) is the lower-risk stock at 0. 05β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately 1137% more volatile than DVA relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 13% for DaVita Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — DVA or UNH?

By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.

8% versus 6. 5% for DaVita Inc. (DVA). On earnings-per-share growth, the picture is similar: DaVita Inc. grew EPS -11. 4% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, UNH leads at 11. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — DVA or UNH?

DaVita Inc.

(DVA) is the more profitable company, earning 5. 5% net margin versus 2. 7% for UnitedHealth Group Incorporated — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DVA leads at 14. 7% versus 4. 2% for UNH. At the gross margin level — before operating expenses — DVA leads at 27. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is DVA or UNH more undervalued right now?

On forward earnings alone, DaVita Inc.

(DVA) trades at 13. 7x forward P/E versus 20. 1x for UnitedHealth Group Incorporated — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UNH: 4. 9% to $385. 43.

08

Which pays a better dividend — DVA or UNH?

In this comparison, UNH (2.

4% yield) pays a dividend. DVA does not pay a meaningful dividend and should not be held primarily for income.

09

Is DVA or UNH better for a retirement portfolio?

For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

59), 2. 4% yield, +220. 3% 10Y return). Both have compounded well over 10 years (UNH: +220. 3%, DVA: +156. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between DVA and UNH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

UNH pays a dividend while DVA does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

DVA

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform DVA and UNH on the metrics below

Revenue Growth>
%
(DVA: 6.0% · UNH: 2.0%)
Net Margin>
%
(DVA: 5.6% · UNH: 2.7%)
P/E Ratio<
x
(DVA: 20.4x · UNH: 27.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.